Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ICU - US81256L2034 - Common Stock

0.34 USD
0 (0%)
Last: 12/3/2025, 6:04:17 PM
0.335 USD
-0.01 (-1.47%)
After Hours: 12/3/2025, 6:04:17 PM
Fundamental Rating

3

Taking everything into account, ICU scores 3 out of 10 in our fundamental rating. ICU was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ICU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ICU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ICU has reported negative net income.
ICU had a negative operating cash flow in the past year.
In the past 5 years ICU always reported negative net income.
In the past 5 years ICU always reported negative operating cash flow.
ICU Yearly Net Income VS EBIT VS OCF VS FCFICU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

ICU has a Return On Assets of -175.01%. This is amonst the worse of the industry: ICU underperforms 89.89% of its industry peers.
Looking at the Return On Equity, with a value of -439.12%, ICU is doing worse than 80.32% of the companies in the same industry.
Industry RankSector Rank
ROA -175.01%
ROE -439.12%
ROIC N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICU Yearly ROA, ROE, ROICICU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 96.48%, ICU belongs to the top of the industry, outperforming 99.47% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for ICU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICU Yearly Profit, Operating, Gross MarginsICU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, ICU has more shares outstanding
ICU has a better debt/assets ratio than last year.
ICU Yearly Shares OutstandingICU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ICU Yearly Total Debt VS Total AssetsICU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -28.18, we must say that ICU is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -28.18, ICU is doing worse than 89.89% of the companies in the same industry.
ICU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -28.18
ROIC/WACCN/A
WACCN/A
ICU Yearly LT Debt VS Equity VS FCFICU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

A Current Ratio of 1.52 indicates that ICU should not have too much problems paying its short term obligations.
ICU has a worse Current ratio (1.52) than 73.94% of its industry peers.
A Quick Ratio of 1.50 indicates that ICU should not have too much problems paying its short term obligations.
ICU has a Quick ratio of 1.50. This is comparable to the rest of the industry: ICU outperforms 41.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.5
ICU Yearly Current Assets VS Current LiabilitesICU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 86.67% over the past year.
EPS 1Y (TTM)86.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%

3.2 Future

ICU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.34% yearly.
ICU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 203.56% yearly.
EPS Next Y90.65%
EPS Next 2Y39.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year464.08%
Revenue Next 2Y203.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 500K 1M 1.5M 2M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ICU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICU Price Earnings VS Forward Price EarningsICU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICU Per share dataICU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ICU's earnings are expected to grow with 39.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.34%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ICU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (12/3/2025, 6:04:17 PM)

After market: 0.335 -0.01 (-1.47%)

0.34

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-25 2026-03-25
Inst Owners1.73%
Inst Owner Change127.2%
Ins Owners0.95%
Ins Owner Change1.18%
Market Cap12.26M
Revenue(TTM)135.00K
Net Income(TTM)-14.67M
Analysts80
Price Target1.02 (200%)
Short Float %1.12%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.39%
Min EPS beat(2)16.22%
Max EPS beat(2)58.55%
EPS beat(4)3
Avg EPS beat(4)19.57%
Min EPS beat(4)-0.12%
Max EPS beat(4)58.55%
EPS beat(8)4
Avg EPS beat(8)-3.7%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)80.36%
Min Revenue beat(2)67.33%
Max Revenue beat(2)93.4%
Revenue beat(4)2
Avg Revenue beat(4)23.68%
Min Revenue beat(4)-55.78%
Max Revenue beat(4)93.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-50%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16
P/FCF N/A
P/OCF N/A
P/B 3.67
P/tB 3.67
EV/EBITDA N/A
EPS(TTM)-1.65
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.02
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -175.01%
ROE -439.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.48%
FCFM N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.5
Altman-Z -28.18
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.18%
EPS Next Y90.65%
EPS Next 2Y39.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%
Revenue Next Year464.08%
Revenue Next 2Y203.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.92%
OCF growth 3YN/A
OCF growth 5YN/A

SEASTAR MEDICAL HOLDING CORP / ICU FAQ

Can you provide the ChartMill fundamental rating for SEASTAR MEDICAL HOLDING CORP?

ChartMill assigns a fundamental rating of 3 / 10 to ICU.


What is the valuation status of SEASTAR MEDICAL HOLDING CORP (ICU) stock?

ChartMill assigns a valuation rating of 1 / 10 to SEASTAR MEDICAL HOLDING CORP (ICU). This can be considered as Overvalued.


How profitable is SEASTAR MEDICAL HOLDING CORP (ICU) stock?

SEASTAR MEDICAL HOLDING CORP (ICU) has a profitability rating of 1 / 10.


What is the earnings growth outlook for SEASTAR MEDICAL HOLDING CORP?

The Earnings per Share (EPS) of SEASTAR MEDICAL HOLDING CORP (ICU) is expected to grow by 90.65% in the next year.